Patrik Brundin Archives

February 12, 2020 $4.5 million co-funding agreement for Parkinson’s research announced

NOTE: This release was originally published by The Cure Parkinson’s Trust LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute…

January 12, 2020 Phase II clinical trial of respiratory drug for treatment of Parkinson's disease reveals promising results

NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association (JAMA)…

October 20, 2019 Can a diabetes drug slow or stop a devastating neurodegenerative disease?

Philip Fortier is on a mission: to find a cure for multiple system atrophy (MSA), a devastating neurodegenerative disease that lacks an effective way to…

October 20, 2019 Researchers begin trial of drug to slow progression of neurodegenerative condition multiple system atrophy

NOTE: This release was originally published by University College London, here. Researchers at UCL Queen Square Institute of Neurology (IoN) and the UCLH National…

April 10, 2019 World Parkinson’s Day: Reasons for hope

In honor of World Parkinson’s Day, we asked scientists in our Center for Neurodegenerative Science what makes them most hopeful and most excited for the…

January 29, 2019 Australian Government invests in innovative genomic testing in Linked Clinical Trials program

This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here. It was announced today that the Australian Parkinson's…

October 30, 2018 Appendix identified as a potential starting point for Parkinson’s disease

GRAND RAPIDS, Mich. (Oct. 31, 2018) — Removing the appendix early in life reduces the risk of developing Parkinson’s disease by 19 to 25 percent,…

October 10, 2018 ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease

Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a week ago, the…